共 31 条
- [1] Verguet S(2014)Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis Health Econ. 24 318-332
- [2] Laxminarayan R(2015)Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis Lancet Glob Health 3 e288-e296
- [3] Jamison DT(2007)Treatment and prevention of mental disorders in low-income and middle-income countries Lancet 370 991-1005
- [4] Verguet S(2008)Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis Bull World Health Organ 86 542-551
- [5] Patel V(2012)Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study BMJ 344 e609-32
- [6] Chisholm D(2012)Economic burden of schizophrenia: empirical analyses from a survey in Thailand J Ment Health Policy Econ 15 25-2756
- [7] Chisholm D(2015)Cost-effectiveness of the Mental Health and Development model for schizophrenia-spectrum and bipolar disorders in rural Kenya Psychol Med 45 2747-S69
- [8] Saxena S(2009)Cost-effectiveness of long-acting Risperidone injection versus alternative atypical antipsychotic agents in patients with schizophrenia in China Value Health 12 S66-582
- [9] Phanthunane P(2011)Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia Cost Eff Resour Alloc: C/E 9 6-1988
- [10] de Menil V(2013)Efficacy, tolerability and cost effectiveness of zotepine versus olanzapine in patients of acute schizophrenia Int J Basic Clin Pharmacol 2 577-s78